Methyltriethoxysilane

We are Methyltriethoxysilane CAS:2031-67-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Methyltriethoxysilane
CAS.NO:2031-67-6
Synonyms:Silane, triethoxymethyl-; Dynasylan MTES; Triethoxymethylsilane;
Molecular Formula:C7H18O3Si
Molecular Weight:178.30200
 
Physical and Chemical Properties:
Density:0.895;
Boiling point:141-143oC;
Flash point:30oC;
Index of Refraction:1.3832;
 
Specification:
Appearance:Colorless clear liquid
Purity(GC):≥99.0%
 
Packing:190 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is highly miscible with standard organic solvents, such as alcohols, hydrocarbons and acetone.
It is practically insoluble in neutral water and reacts only slowly to form silanols and higher condensation products.
Addition of a hydrolytic catalyst (inorganic/organic acids, ammonia or amines) accelerates the hydrolysis of it substantially.
It may be used as water repellent to improve fillers dispersibility and reduces their sedimentation tendency.
It may be used as an important component for sol-gel coating, silicone resins and silicone rubber.

Methyltriethoxysilane


Related News: At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.1-BROMO-2-FLUORO-4-IODOBENZENE CAS:136434-77-0 This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.(4R, 5S) -5- (3,5-bis (trifluorometil) fenil) -4-metiloxazolidin-2-ona CAS:875444-08-9 As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.42858-60-6 Inceptua has global operations with local offices across Europe, USA, and AsiaThis part is mainly anti-tumor drugs, prostate drugs and certain hormone drugs.

Related Products
Product Name
N-(4-Methylphenyl)-3-oxobutanamide View Details
Nalpha-FMOC-L-Glutamine View Details
Ethyl 2-bromovalerate View Details
Methyl 4-bromobutyrate manufacturer 2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropanoic acid manufacturer 1,4-Dibromobutane manufacturer 2-[[(2R)-2-amino-4-methylpentanoyl]amino]acetic acid manufacturer 2-Chloro-1-cyclopropyl-2-(2-fluorophenyl)ethanone manufacturer